Originally published on October 13, 2022, this episode features Luis in conversation with Dr. Paul Hergenrother from the University of Illinois. Dr. Hergenrother discusses Fabimycin, an antibiotic candidate targeting gram-negative bacteria. What is Fabimycin’s mechanism of action? Which bacteria is it active against? Is there any intrinsic resistance? Tune in to find out!

Link to article: https://pubs.acs.org/doi/10.1021/acscentsci.2c00598

Questions? Feedback? Send those to [email protected]

Want to support the podcast? Here's how:

Venmo: https://venmo.com/u/letstalkmicro

Buy me a Ko-fi: https://ko-fi.com/letstalkmicro